Hired someone new and exciting? Promoted a rising star? Finally solved this spot difficult to fill? Share the news with us and we will share with others. This is true. Send us your changes and we will find a house for them . Do not be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Do you recognize somebody?
And here is our usual chronicle in which we highlight a different person each week. This time, we note that Epirus Biopharmaceuticals hired Vincent Aurentz as Chief Business Officer. Previously, he led HemoShear Therapeutics and previously an Executive Vice President at Merck KGgA. He was also Executive Vice President at Quintiles.
Viamet Pharmaceuticals hired Volker Herrmann as commercial director;
Insys Therapeutics says Michael Babich has resigned as CEO and President
Insys Therapeutics Appointed John Kapoor to Babich's Place as CEO and President
Lupine appoints Fabrice Egros president of his Asia-Pacific region and Japan;
Astellas hired Peter Sandor as vice president, chief of oncology therapeutics in marketing strategy;
OticPharma hired Catherine Turkel as Senior Vice President, Clinical R & D and Chief Development Officer;
Arog Pharmaceuticals hired Ada Braun as Senior Vice President of Clinical Development;
Biota Pharmaceuticals hired Mark Colonnese as Executive Vice President and Chief Financial Officer;
T2 Biosystems hired David Harding as commercial director;
Abzena hired Campbell Bunce as Senior Vice President of Scientific Operations;
TWi Pharmaceuticals says that Tina Guilder has resigned as CEO and President;
TWi Pharmaceuticals Appoints Chih-Ming Chen as Director General and Acting President